FDA Allows a Phase II Clinical Trial in Stroke for NuvOx Pharma’s DDFPe

The FDA has allowed an Investigational New Drug (IND) application to initiate a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Read more...